Platelet Rich Plasma Study in Lower Extremity Bypass Surgery (PRP)

This study has been completed.
Sponsor:
Collaborator:
Biomet, Inc.
Information provided by:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT00517452
First received: August 16, 2007
Last updated: January 4, 2011
Last verified: January 2011
  Purpose

The use of platelet rich plasma will decrease wound infection postop.


Condition Phase
Atherosclerosis
Phase 2
Phase 3

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.

Resource links provided by NLM:


Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Wound healing [ Time Frame: 4- 6 weeks post op ] [ Designated as safety issue: No ]

Enrollment: 81
Study Start Date: May 2007
Study Completion Date: December 2007
Groups/Cohorts
Platelet Rich Plasma
Group received platelet rich plasma and observed over a period of 30 days or until wound closure
Standard Wound Care
Group was treated as per standard care

  Eligibility

Ages Eligible for Study:   35 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision

Criteria

Inclusion Criteria:

  • Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision Exclusion Criteria:Patients requiring emergent procedures, unable to give informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00517452

Sponsors and Collaborators
Lawson Health Research Institute
Biomet, Inc.
Investigators
Principal Investigator: Kirk D Lawlor London Health Sciences Centre, University of Western Ontario
  More Information

No publications provided

Responsible Party: Dr. K. Lawlor, Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00517452     History of Changes
Other Study ID Numbers: R-07-098
Study First Received: August 16, 2007
Last Updated: January 4, 2011
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 27, 2014